Skip to content

RNTX RNTX Debt-to-equity

Debt-to-equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
2.2×-0.6×
Gilead Sciences logo
Gilead SciencesGILD
0.9×-0.4×
AbbVie logo
AbbVieABBV
46.6×+38.6×
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
0.2×0.0×
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
0.0×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
8.4×+6.9×

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+177%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Current ratio0.4×-1.0×

Where this comes from

Calculated from RNTX’s reported figures.

Based on the most recent quarter.

The official record: RNTX’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's debt-to-equity?
RNTX (RNTX) reported debt-to-equity of 0× in Q4 2023.
How has RNTX's debt-to-equity changed year-over-year?
RNTX's debt-to-equity increased by 169.2% year-over-year, from 0× to 0×.
What is the long-term trend for RNTX's debt-to-equity?
Over 2 years (2021 to 2023), RNTX's debt-to-equity has grown at a 37.5% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.